Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Richard S. Levy Insider Profile
207 Followers
Richard S. Levy, EVP, Chief Drug Dev Officer at Incyte, holds 11.01K shares in Madrigal Pharmaceuticals (Ticker: MDGL), holds 12.90K shares in Kiniksa Pharmaceuticals (Ticker: KNSA), holds 1.00K shares in Kodiak Sciences (Ticker: KOD).
Profitable Transactions
6 out of 6 Profitable Transactions
Average Return
+442.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Richard S. Levy holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Aug 22, 2017 - Aug 22, 2018
Return:+800.00%
The most profitable trade made by Richard S. Levy
Richard S. Levy's Trading History
Incyte
Jan 08, 2016
EVP, Chief Drug Dev Officer
Uninformative Buy
72.13K
$1.11M
Madrigal Pharmaceuticals
Jun 27, 2024
Director
Uninformative Buy
―
$3.16M
Neurogene
―
Director
―
―
Kiniksa Pharmaceuticals
Jun 07, 2024
Director
Uninformative Buy
85.36K
$273.80K
Kodiak Sciences
Mar 24, 2020
Director
Informative Buy
44.33K
$2.87K
Protara Therapeutics
Jan 13, 2020
Director
Uninformative Buy
―
$69.13K
Constellation Pharmaceuticals
―
―
―
―
List of latest transactions for each holding click on a transaction to see Richard S. Levy's performance on stock
You May Also Like
Richard S. Levy insider profile FAQ
What is the percentage of profitable transactions made by Richard S. Levy?
The percentage of profitable transactions made by Richard S. Levy is 100%.
What is the average return per transaction made by Richard S. Levy?
The average return per transaction made by Richard S. Levy is 442.60%.
What stocks does Richard S. Levy hold?
Richard S. Levy holds: INCY, MDGL, NGNE, KNSA, KOD, TARA, CNST stocks.
What was Richard S. Levy’s latest transaction?
Richard S. Levy latest transaction was an Uninformative Buy of ―.
What was Richard S. Levy's most profitable transaction?
Richard S. Levy’s most profitable transaction was an Informative Buy of MDGL stock on August 22, 2017. The return on the trade was 800.00%.
What is Richard S. Levy's role in Incyte?
Richard S. Levy's role in Incyte is EVP, Chief Drug Dev Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.